1-(2,4-diethylthiophen-3-yl)-1-[(1-methylpiperidin-3-yl)-(1-methylpyrazol-4-yl)sulfamoyl]urea
C19H30N6O3S2 — CID 175712998
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2,4-diethylthiophen-3-yl)-1-[(1-methylpiperidin-3-yl)-(1-methylpyrazol-4-yl)sulfamoyl]urea
1-(2,4-diethylthiophen-3-yl)-1-[(1-methylpiperidin-3-yl)-(1-methylpyrazol-4-yl)sulfamoyl]urea (PubChem CID 175712998) has the molecular formula C19H30N6O3S2 and a molecular weight of 454.62 g/mol. Its IUPAC name is 1-(2,4-diethylthiophen-3-yl)-1-[(1-methylpiperidin-3-yl)-(1-methylpyrazol-4-yl)sulfamoyl]urea.
Molecular Properties
| Compound Name | 1-(2,4-diethylthiophen-3-yl)-1-[(1-methylpiperidin-3-yl)-(1-methylpyrazol-4-yl)sulfamoyl]urea |
|---|---|
| PubChem CID | 175712998 |
| Molecular Formula | C19H30N6O3S2 |
| Molecular Weight | 454.62 g/mol |
| Exact Mass | 454.18 |
| IUPAC Name | 1-(2,4-diethylthiophen-3-yl)-1-[(1-methylpiperidin-3-yl)-(1-methylpyrazol-4-yl)sulfamoyl]urea |
| SMILES | CCc1csc(CC)c1N(C(N)=O)S(=O)(=O)N(c1cnn(C)c1)C1CCCN(C)C1 |
| InChI | InChI=1S/C19H30N6O3S2/c1-5-14-13-29-17(6-2)18(14)25(19(20)26)30(27,28)24(16-10-21-23(4)12-16)15-8-7-9-22(3)11-15/h10,12-13,15H,5-9,11H2,1-4H3,(H2,20,26) |
| InChIKey | QWEQLIRYXGEGMJ-UHFFFAOYSA-N |
| XLogP | 2.34 |
| TPSA | 104.77 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 454.62 |
| LogP ≤ 5 | 2.34 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175712998 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.